Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Aug…
Biotechnology
US, Bedford [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Stoke Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
Stoke Therapeutics, Inc. has no acquisition track records yet.